Related references
Note: Only part of the references are listed.Chemotherapy exacerbates ovarian cancer cell migration and cancer stem cell-like characteristics through GLI1
Yawei Zhao et al.
BRITISH JOURNAL OF CANCER (2020)
Human omental adipose-derived mesenchymal stem cells enhance autophagy in ovarian carcinoma cells through the STAT3 signalling pathway
Yijing Chu et al.
CELLULAR SIGNALLING (2020)
Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomised trial
Takashi Onda et al.
EUROPEAN JOURNAL OF CANCER (2020)
Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways
Go J. Yoshida
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
A novel c-Kit/phospho-prohibitin axis enhances ovarian cancer stemness and chemoresistance via Notch3-PBX1 and β-catenin-ABCG2 signaling
Chia-Hsun Fang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2020)
CD133: beyond a cancer stem cell biomarker
Amir Barzegar Behrooz et al.
JOURNAL OF DRUG TARGETING (2019)
Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer
Qinglei Gao et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
A Pan-ALDH1A Inhibitor Induces Necroptosis in Ovarian Cancer Stem-like Cells
Ilana Chefetz et al.
CELL REPORTS (2019)
Activated Fibroblast Program Orchestrates Tumor Initiation and Progression; Molecular Mechanisms and the Associated Therapeutic Strategies
Go J. Yoshida et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Ovarian Cancer Stemness: Biological and Clinical Implications for Metastasis and Chemotherapy Resistance
Takeshi Motohara et al.
CANCERS (2019)
Matrix Hyaluronan-CD44 Interaction Activates MicroRNA and LncRNA Signaling Associated With Chemoresistance, Invasion, and Tumor Progression
Lilly Y. W. Bourguignon
FRONTIERS IN ONCOLOGY (2019)
Management of Platinum-Resistant, Relapsed Epithelial Ovarian Cancer and New Drug Perspectives
Eric Pujade-Lauraine et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Ovarian cancer stem cells and their role in drug resistance
Zalitha Pieterse et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2019)
Overview of CD24 as a new molecular marker in ovarian cancer
Vahideh Tarhriz et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment
Takeshi Motohara et al.
ONCOGENE (2019)
CD10+ GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness
Shicheng Su et al.
CELL (2018)
Consensus on Molecular Subtypes of High-Grade Serous Ovarian Carcinoma
Gregory M. Chen et al.
CLINICAL CANCER RESEARCH (2018)
Tumor associated macrophages in gynecologic cancers
Venkatesh Krishnan et al.
GYNECOLOGIC ONCOLOGY (2018)
Blockade of nuclear factor-κB (NF-κB) pathway inhibits growth and induces apoptosis in chemoresistant ovarian carcinoma cells
Majid Momeny et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
Aggressive serous epithelial ovarian cancer is potentially propagated by EpCAM+CD45+ phenotype
Md Zahid Akhter et al.
ONCOGENE (2018)
Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer
Sara Al Habyan et al.
ONCOGENE (2018)
miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers
Anne-Marie Givel et al.
NATURE COMMUNICATIONS (2018)
The role of neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer: a systematic review and meta-analysis of randomized controlled trials and observational studies
Meng Qin et al.
Oncotarget (2018)
Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?
Lynn Roy et al.
CANCERS (2018)
Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials
Ignace Vergote et al.
LANCET ONCOLOGY (2018)
Targeting macrophages: therapeutic approaches in cancer
Luca Cassetta et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
CD117/c-kit in Cancer Stem Cell-Mediated Progression and Therapeutic Resistance
Brittni M. Foster et al.
BIOMEDICINES (2018)
CD133 Promotes Adhesion to the Ovarian Cancer Metastatic Niche
Lynn Roy et al.
CANCER GROWTH AND METASTASIS (2018)
Ovarian cancer stem cells: still an elusive entity?
Michela Lupia et al.
MOLECULAR CANCER (2017)
Cancer stem cells: The root of tumor recurrence and metastases
Claudia Peitzsch et al.
SEMINARS IN CANCER BIOLOGY (2017)
Ovarian cancer stem cells more questions than answers
Petronella Beatrix Ottevanger
SEMINARS IN CANCER BIOLOGY (2017)
Human omental adipose-derived mesenchymal stem cell-conditioned medium alters the proteomic profile of epithelial ovarian cancer cell lines in vitro
Yanling Zhang et al.
ONCOTARGETS AND THERAPY (2017)
The impact of EpCAM expression on response to chemotherapy and clinical outcomes in patients with epithelial ovarian cancer
Shingo Tayama et al.
ONCOTARGET (2017)
The Crosstalk between Ovarian Cancer Stem Cell Niche and the Tumor Microenvironment
Manuel Varas-Godoy et al.
STEM CELLS INTERNATIONAL (2017)
Mesenchymal stromal cells' role in tumor microenvironment: involvement of signaling pathways
Armel Herve Nwabo Kamdje et al.
CANCER BIOLOGY & MEDICINE (2017)
The Unique Molecular and Cellular Microenvironment of Ovarian Cancer
Thomas Worzfeld et al.
FRONTIERS IN ONCOLOGY (2017)
NFκB Promotes Ovarian Tumorigenesis via Classical Pathways That Support Proliferative Cancer Cells and Alternative Pathways That Support ALDH+ Cancer Stem-like Cells
Carrie D. House et al.
CANCER RESEARCH (2017)
NF-κB Participates in the Stem Cell Phenotype of Ovarian Cancer Cells
Carolina Gonzalez-Torres et al.
ARCHIVES OF MEDICAL RESEARCH (2017)
TAMeless traitors: macrophages in cancer progression and metastasis
Shweta Aras et al.
BRITISH JOURNAL OF CANCER (2017)
The heterogeneity of cancer stem-like cells at the invasive front
Go J. Yoshida
CANCER CELL INTERNATIONAL (2017)
Therapeutic strategies targeting cancer stem cells
Go J. Yoshida et al.
CANCER SCIENCE (2016)
Salt-Inducible Kinase 2 Couples Ovarian Cancer Cell Metabolism with Survival at the Adipocyte-Rich Metastatic Niche
Fabrizio Miranda et al.
CANCER CELL (2016)
EGFL6 Regulates the Asymmetric Division, Maintenance, and Metastasis of ALDH+ Ovarian Cancer Cells
Shoumei Bai et al.
CANCER RESEARCH (2016)
Targeting the tumour microenvironment in ovarian cancer
Jean M. Hansen et al.
EUROPEAN JOURNAL OF CANCER (2016)
Carcinoma-associated fibroblasts: orchestrating the composition of malignancy
Philippe Gascard et al.
GENES & DEVELOPMENT (2016)
Targeting the hallmarks of ovarian cancer: The big picture
M. Petrillo et al.
GYNECOLOGIC ONCOLOGY (2016)
Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer
Mingzhu Yin et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer
Larissa A. Meyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
CD44 Variant 6 as a Predictive Biomarker for Distant Metastasis in Patients With Epithelial Ovarian Cancer
Takeshi Motohara et al.
OBSTETRICS AND GYNECOLOGY (2016)
Aldehyde dehydrogenase 1A1 in stem cells and cancer
Hiroyuki Tomita et al.
ONCOTARGET (2016)
Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis
Tsz-Lun Yeung et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2015)
Human mesenchymal stem cells - current trends and future prospective
Imran Ullah et al.
BIOSCIENCE REPORTS (2015)
CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer
Francisca Tjhay et al.
CANCER SCIENCE (2015)
The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?
Vicki Plaks et al.
CELL STEM CELL (2015)
Differential activation of NF-kappa B signaling is associated with platinum and taxane resistance in MyD88 deficient epithelial ovarian cancer cells
Snehal M. Gaikwad et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2015)
Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?
Axel Schulenburg et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
Sean Kehoe et al.
LANCET (2015)
CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis
Daniela Burgos-Ojeda et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Whole-genome characterization of chemoresistant ovarian cancer
Ann-Marie Patch et al.
NATURE (2015)
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update
Naoko Takebe et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Identifying an ovarian cancer cell hierarchy regulated by bone morphogenetic protein 2
Yun-Jung Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Accumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer
Tiyasha H. Ayub et al.
ONCOTARGET (2015)
Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance
Anil Belur Nagaraj et al.
ONCOTARGET (2015)
Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer
Yan Gao et al.
ONCOTARGET (2015)
Metabolic orchestration between cancer cells and tumor microenvironment as a co-evolutionary source of chemoresistance in ovarian cancer: A therapeutic implication
Dong Hoon Suh et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition
Benoit Thibault et al.
CANCER AND METASTASIS REVIEWS (2014)
Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread
Sunila Pradeep et al.
CANCER CELL (2014)
Induction of multipotency in umbilical cord-derived mesenchymal stem cells cultivated under suspension conditions
Fatemeh Amiri et al.
CELL STRESS & CHAPERONES (2014)
C-KIT Signaling in Cancer Treatment
Karmen Stankov et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: Correlation of CD163 expression, cytokine levels and early relapse
Silke Reinartz et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets
Nuzhat Ahmed et al.
MOLECULAR ASPECTS OF MEDICINE (2014)
Ovarian Cancer Spheroid Cells with Stem Cell-Like Properties Contribute to Tumor Generation, Metastasis and Chemotherapy Resistance through Hypoxia-Resistant Metabolism
Jianqun Liao et al.
PLOS ONE (2014)
Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling
Wan-Jiun Chen et al.
NATURE COMMUNICATIONS (2014)
Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
Theerawut Chanmee et al.
CANCERS (2014)
Ovarian cancer stem cells: Working towards the root of sternness
Rosemary Foster et al.
CANCER LETTERS (2013)
New Strategies in the Treatment of Ovarian Cancer: Current Clinical Perspectives and Future Potential
Susana Banerjee et al.
CLINICAL CANCER RESEARCH (2013)
Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma
J. Alejandro Rauh-Hain et al.
GYNECOLOGIC ONCOLOGY (2013)
Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden
Khalid Abubaker et al.
MOLECULAR CANCER (2013)
Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche
Andrea Flesken-Nikitin et al.
NATURE (2013)
c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling
W. K. Chau et al.
ONCOGENE (2013)
Niche-Dependent Gene Expression Profile of Intratumoral Heterogeneous Ovarian Cancer Stem Cell Populations
Sagi Abelson et al.
PLOS ONE (2013)
Integrating Genomic, Epigenomic, and Transcriptomic Features Reveals Modular Signatures Underlying Poor Prognosis in Ovarian Cancer
Wei Zhang et al.
CELL REPORTS (2013)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
Cancer Stem Cells: Current Status and Evolving Complexities
Jane E. Visvader et al.
CELL STEM CELL (2012)
Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer
Adam D. Steg et al.
CLINICAL CANCER RESEARCH (2012)
Omental Adipose Tissue-Derived Stromal Cells Promote Vascularization and Growth of Endometrial Tumors
Ann H. Klopp et al.
CLINICAL CANCER RESEARCH (2012)
Functional interaction between peritoneal mesothelial cells and stem cells of ovarian yolk sac tumor (SC-OYST) in peritoneal dissemination
Hiroko Mitsui et al.
GYNECOLOGIC ONCOLOGY (2012)
The evolving concept of cancer and metastasis stem cells
Irene Baccelli et al.
JOURNAL OF CELL BIOLOGY (2012)
HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts
Song Yi Ko et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
STEM CELL FACTOR RECEPTOR/c-KIT: FROM BASIC SCIENCE TO CLINICAL IMPLICATIONS
Johan Lennartsson et al.
PHYSIOLOGICAL REVIEWS (2012)
Mesenchymal Cell Interaction with Ovarian Cancer Cells Triggers Pro-Metastatic Properties
Raphael Lis et al.
PLOS ONE (2012)
Isolation and Characterization of Tumor Cells from the Ascites of Ovarian Cancer Patients: Molecular Phenotype of Chemoresistant Ovarian Tumors
Ardian Latifi et al.
PLOS ONE (2012)
Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance
Katia Meirelles et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy
Shannon M. McAuliffe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Overcoming Challenges of Ovarian Cancer Stem Cells: Novel Therapeutic Approaches
Cristobal Aguilar-Gallardo et al.
STEM CELL REVIEWS AND REPORTS (2012)
Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell
Toshifumi Yae et al.
NATURE COMMUNICATIONS (2012)
MicroRNAs Reprogram Normal Fibroblasts into Cancer-Associated Fibroblasts in Ovarian Cancer
Anirban K. Mitra et al.
CANCER DISCOVERY (2012)
Mesenchymal stem cells in tumor development Emerging roles and concepts
Benjamin G. Cuiffo et al.
CELL ADHESION & MIGRATION (2012)
Mesenchymal Stem Cells Isolated from Adipose and Other Tissues: Basic Biological Properties and Clinical Applications
Hakan Orbay et al.
STEM CELLS INTERNATIONAL (2012)
Aldehyde Dehydrogenase Inhibitors: a Comprehensive Review of the Pharmacology, Mechanism of Action, Substrate Specificity, and Clinical Application
Vindhya Koppaka et al.
PHARMACOLOGICAL REVIEWS (2012)
Regulation of Inflammation by the NF-κB Pathway in Ovarian Cancer Stem Cells
Aliza L. Leizer et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2011)
CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc- and Thereby Promotes Tumor Growth
Takatsugu Ishimoto et al.
CANCER CELL (2011)
Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival
Ines A. Silva et al.
CANCER RESEARCH (2011)
Cancer Stem Cell Niche: The Place to Be
Tijana Borovski et al.
CANCER RESEARCH (2011)
Transient depletion of p53 followed by transduction of c-Myc and K-Ras converts ovarian stem-like cells into tumor-initiating cells
Takeshi Motohara et al.
CARCINOGENESIS (2011)
Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome
Lijing Luo et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2011)
Exosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofibroblasts
Jung Ah Cho et al.
GYNECOLOGIC ONCOLOGY (2011)
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-Shifting the paradigm
Robert J. Kurman et al.
HUMAN PATHOLOGY (2011)
Cisplatin Treatment of Primary and Metastatic Epithelial Ovarian Carcinomas Generates Residual Cells With Mesenchymal Stem Cell-Like Profile
Ardian Latifi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production
Karen McLean et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
Kristin M. Nieman et al.
NATURE MEDICINE (2011)
Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells
Masahisa Jinushi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Concise Review: Mesenchymal Stem Cell Tumor-Homing: Detection Methods in Disease Model Systems
Michaela R. Reagan et al.
STEM CELLS (2011)
Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
David G. DeNardo et al.
CANCER DISCOVERY (2011)
Notch3 Overexpression Is Related to the Recurrence of Ovarian Cancer and Confers Resistance to Carboplatin
Joon Tae Park et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Ovarian Cancer Development and Metastasis
Ernst Langyel
AMERICAN JOURNAL OF PATHOLOGY (2010)
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Robert J. Kurman et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Long-term oncological outcomes of ovarian serous carcinomas with psammoma bodies: A novel insight into the molecular pathogenesis of ovarian epithelial carcinoma
Takeshi Motohara et al.
CANCER SCIENCE (2010)
Involvement of M2-polarized macrophages in the ascites from advanced epithelial ovarian carcinoma in tumor progression via Stat3 activation
Kiyomi Takaishi et al.
CANCER SCIENCE (2010)
EpCAM in carcinogenesis: the good, the bad or the ugly
Bernardina T. F. van der Gun et al.
CARCINOGENESIS (2010)
The therapeutic promise of the cancer stem cell concept
Natasha Y. Frank et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer
Charles N. Landen et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Glioma cancer stem cells induce immunosuppressive macrophages/microglia
Adam Wu et al.
NEURO-ONCOLOGY (2010)
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
Ignace Vergote et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells
M-Q Gao et al.
ONCOGENE (2010)
Molecular phenotyping of human ovarian cancer stem cells unravel the mechanisms for repair and chemo-resistance
Ayesha B. Alvero et al.
CELL CYCLE (2009)
Nuclear signalling by tumour-associated antigen EpCAM
Dorothea Maetzel et al.
NATURE CELL BIOLOGY (2009)
Epigenetic regulation of CD133 and tumorigenicity of CD133+ovarian cancer cells
T. Baba et al.
ONCOGENE (2009)
The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells
Seth B. Coffelt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
CD133 Expression Defines a Tumor Initiating Cell Population in Primary Human Ovarian Cancer
Michael D. Curley et al.
STEM CELLS (2009)
CD133-Expressing Stem Cells Associated with Ovarian Metastases Establish an Endothelial Hierarchy and Contribute to Tumor Vasculature
Anjali P. Kusumbe et al.
STEM CELLS (2009)
Identification and characterization of ovarian cancer-initiating cells from primary human tumors
Shu Zhang et al.
CANCER RESEARCH (2008)
Stem cells and niches: Mechanisms that promote stem cell maintenance throughout life
Sean J. Morrison et al.
CELL (2008)
Cancer-derived lysophosphatidic acid stimulates differentiation of human mesenchymal stem cells to myofibroblast-like cells
Eun Su Jeon et al.
STEM CELLS (2008)
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
Martin Koebel et al.
PLOS MEDICINE (2008)
Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice
Toni M. Robinson-Smith et al.
CANCER RESEARCH (2007)
Identification of pancreatic cancer stem cells
Chenwei Li et al.
CANCER RESEARCH (2007)
A perivascular niche for brain tumor stem cells
Christopher Calabrese et al.
CANCER CELL (2007)
Mechanisms of transcoelomic metastasis in ovarian cancer
David S. P. Tan et al.
LANCET ONCOLOGY (2006)
Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness
Paul P. Szotek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy
A Sica et al.
EUROPEAN JOURNAL OF CANCER (2006)
Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer
SA Bapat et al.
CANCER RESEARCH (2005)
Wnt signalling in stem cells and cancer
T Reya et al.
NATURE (2005)
Mechanism and biological significance of CD44 cleavage
O Nagano et al.
CANCER SCIENCE (2004)
Ovarian tumorigenesis - A proposed model based on morphological and molecular genetic analysis
IM Shih et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells
L Kobari et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2001)